Guardant Health
GH
#1521
Rank
NZ$24.91 B
Marketcap
NZ$191.83
Share price
-1.27%
Change (1 day)
187.92%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company